Farmace

What Farmace does

Farmace - Indústria Químico Farmacêutica Cearense LTDA is a privately held Brazilian pharmaceutical manufacturer founded in 1981 and headquartered in Barbalha, Ceará. The company produces more than 80 pharmaceutical presentations organized into two business lines: the Farma line (retail pharmacy products including oral liquids, nasal solutions, topical antiseptics, and simplified notification products) and the Hospitalar line (hospital products including large and small volume parenteral solutions in glass and plastic, hemodialysis electrolyte concentrates, electrolytes, and injectable medications such as analgesics, corticosteroids, and antibiotics). Manufacturing is centralized at the Barbalha plant, which the company describes as equipped with state-of-the-art equipment and supported by a dedicated pharmacovigilance department for post-market surveillance.

Farmace sells exclusively through a network of commercial representatives located across all major Brazilian regions, with offices in at least 13 cities spanning the Northeast, North, Southeast, South, and Center-West. The company does not sell directly via its website; instead, a representative locator and an online ordering portal are used to route orders. Pricing is not publicly disclosed and is handled on a quote basis through commercial representatives. Customer segments include Brazilian hospitals and healthcare networks (Hospitalar line), pharmacy retailers and end-patients (Farma line), and public-sector procurement channels, with international reach extended through a 2024 strategic partnership with CENABAST, Chile's national health supply central, for medication supply to the Chilean healthcare network.

The company is structured as a Sociedade Limitada (LTDA) with no disclosed parent company, no institutional investor mentions, and no public listing. Headcount stands at approximately 2,200 collaborators, up from 27 at founding, and the company continues to invest in workforce development through programs such as the Young Apprentice initiative. Farmace competes in the Brazilian generic and similar drug market, where its competitive positioning is built on ANVISA regulatory compliance, broad national distribution, and portfolio depth in injectables and hospital essentials rather than on differentiated novel molecules or AI-driven capabilities.

Name

Farmace

Legal name

FARMACE - Indústria Químico Farmacêutica Cearense LTDA

Website

https://farmace.com.br

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Farmace is a privately held Brazilian pharmaceutical manufacturer, founded in 1981 and headquartered in Barbalha, Ceará, producing 80+ generic and similar medications across hospital (injectables, hemodialysis concentrates) and retail pharmacy lines, distributed nationwide through a commercial representative network with a recent export partnership into Chile.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Hospital injectables
• Hemodialysis concentrates
• Topical antiseptics

Headquarters

HQ city

Barbalha

HQ country

Brazil

HQ region

Latin America

Offices14 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Farmace manufactures and sells pharmaceutical products through a network of commercial representatives across Brazil. Products include generic medications, similar medications, specific medications, and simplified notification products across hospital and pharmaceutical lines.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

FARMACE manufactures generic, similar, and specific medications along with simplified notification products organized into two commercial lines: the Farma line (retail pharmacy products such as oral liquids, nasal solutions, enemas, topical antiseptics, and external use solutions) and the Hospitalar line (hospital products such as large and small volume parenteral solutions and hemodialysis electrolyte concentrates). The combined catalog comprises more than 80 product presentations manufactured at the Barbalha, Ceará facility and sold to pharmacies, hospitals, healthcare networks, and public health systems.

Product overview

Farmace is a Brazilian pharmaceutical company (FARMACE - Indústria Químico Farmacêutica Cearense LTDA) that manufactures and distributes medications through two main product lines: Farma (retail/pharmacy line) and Hospitalar (hospital line). The portfolio consists of more than 80 presentations distributed across multiple product categories including Oral Liquids, Nasal Solutions, Enema, Topical Antiseptics, External Use solutions, Small Volume Parenteral Solutions in Glass, Parenteral Solutions in Plastic Packaging, Hemodialysis Electrolyte Concentrates, Generic, Similar, and Specific medications. Key products include solutions for injection (glucose, saline, Ringer's, mannitol), oral liquids (ambroxol, dexamethasone, dipyrone, paracetamol, dexchlorpheniramine), topical antiseptics (chlorhexidine), nasal solutions, hemodialysis concentrates, and various other pharmaceutical preparations. Products are sold through commercial representatives across Brazil, with the company's manufacturing facility located in Barbalha, Ceará.

Differentiator

Problem solved

Functional benefit

Products and services

• Farma Line — Retail Pharmaceutical Products Retail pharmacy product line containing generic, similar, and specific medications including oral liquids, nasal solutions, enemas, topical antiseptics, and external use solutions distributed to retail pharmacies across Brazil.
• Hospitalar Line — Hospital Pharmaceutical Products Hospital product line containing large and small volume parenteral solutions, hemodialysis electrolyte concentrates, and other hospital-grade medications distributed to hospitals, healthcare networks, and public health systems in Brazil and, via CENABAST, in Chile.
• Hemodialysis Electrolyte Concentrates Specialized electrolyte concentrate formulations used in hemodialysis treatment, sold to hospitals and dialysis clinics through the Hospitalar line as part of Farmace's 80+ product catalog.
• Parenteral Solutions (Large and Small Volume) Sterile injectable solutions in various volumes — large-volume parenterals (such as IV fluids) and small-volume parenterals — used in hospital settings for fluid replacement, medication delivery, and parenteral nutrition; part of the Hospitalar line.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• CENABAST (Central de Abastecimento do Sistema Nacional de Saúde do Chile)coreStrategic or Co-development Partner · 3 December 2024Strategic partnership with CENABAST, Chile's National Health System Supply Central, to ensure continuity of medication supply for the Chilean healthcare network. During the official visit, CENABAST director Jaime Espina visited Farmace's plant and production process. This agreement reinforces Farmace's commitment to contributing to global health and well-being.

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Biolab Sanus: Brazilian pharmaceutical company with generics, branded, and hospital lines, with comparable product breadth and Brazilian market footprint to Farmace.
• Eurofarma Laboratórios: Brazilian pharmaceutical company with generics, branded, and hospital product lines, national distribution, and Latin American export presence comparable to Farmace's profile.
• Prati-Donaduzzi: Brazilian generic pharmaceutical manufacturer with hospital and retail presence, comparable scale, product breadth, and distribution approach to Farmace.
• Geolab: Brazilian generic pharmaceutical manufacturer with hospital and retail product portfolio, comparable scale, manufacturing approach, and ANVISA-registered portfolio to Farmace.
• Cristália: Brazilian pharmaceutical manufacturer with strong focus on hospital injectables, anesthetics, and specialty parenteral solutions, the closest analog to Farmace's Hospitalar line portfolio and Brazilian market positioning.
• Aché Laboratórios: Brazilian pharmaceutical manufacturer with diversified portfolio across generics, branded, and hospital channels, similar mid-market positioning and channel breadth to Farmace.
• Hipolabor: Brazilian generic pharmaceutical manufacturer with strong hospital injectable focus, very similar product mix to Farmace's Hospitalar offerings and similar regional distribution model.
• EMS: Brazil's largest generic pharmaceutical manufacturer by volume, with broad retail and hospital portfolio directly comparable to Farmace's Farma and Hospitalar lines and similar generic/SUS positioning.

Broad incumbents

• Sanofi (Brazil operations): Global pharmaceutical company with significant Brazilian operations including the legacy Medley generic brand, competing broadly with Farmace across multiple therapeutic categories and channels.
• Teva Pharmaceutical Industries: Global generic pharmaceutical leader with selective Latin American presence, competing in injectable and oral generics broadly overlapping with Farmace's portfolio categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/farmaceoficial

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farmace